Identification of a dominant CD8+ CTL epitope in the SARS-associated coronavirus 2 spike protein
Authors:
- 1 November 2020
- Vol. 38 (49) , 7697-7701
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
This publication has 18 references indexed in Scilit:
- The pathogenicity of SARS-CoV-2 in hACE2 transgenic miceNature, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- Prospects for a MERS-CoV spike vaccineExpert Review of Vaccines, 2018
- Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infectionVaccine, 2016
- Residue analysis of a CTL epitope of SARS-CoV spike protein by IFN-gamma production and bioinformatics predictionBMC Immunology, 2012
- T Cell Responses to Whole SARS Coronavirus in HumansThe Journal of Immunology, 2008
- Determination of Cellularly Processed HLA-A2402-Restricted Novel CTL Epitopes Derived from Two Cancer Germ Line Genes, MAGE-A4 and SAGEClinical Cancer Research, 2005
- Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike proteinVirology, 2005
- Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor associationProceedings of the National Academy of Sciences, 2004